organization · Reporting owner
Era Regenerative Medicine Ltd
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| REED'S, INC.REED · Entity 7963 | 10% owner | June 04, 2025 | June 11, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
REED'S, INC.
Report date June 04, 2025 · Filed June 11, 2025
Jointly reported with D&D Source of Life Holding Ltd.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 28,214,789 |
Reported balance
After 2025-06-04 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-06-04 · Purchase · Acquired 1,075,269 · Balance 28,214,789 F1: D&D Source of Life Holding Ltd. ("D&D"), participated in the Registrant's PIPE transaction. F2: The purchase price per share was $0.93. F3: Includes 232,108 shares of common stock issuable upon exercise of currently exercisable warrants. F4: Era Regenerative Medicine Ltd.("ERM") holds all the shares in D&D. Dai Siqi, currently the sole director of ERM, has sole voting and dispositive power over the securities of the Registrant held directly by D&D. |
Filing footnotes · ownership attribution and instrument terms
F1: D&D Source of Life Holding Ltd. ("D&D"), participated in the Registrant's PIPE transaction.
F2: The purchase price per share was $0.93.
F3: Includes 232,108 shares of common stock issuable upon exercise of currently exercisable warrants.
F4: Era Regenerative Medicine Ltd.("ERM") holds all the shares in D&D. Dai Siqi, currently the sole director of ERM, has sole voting and dispositive power over the securities of the Registrant held directly by D&D.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2025 Filed Jun 11, 2025 20:36 UTC | REED'S, INC. REED · Entity 7963 | PurchaseCommon Stock | 1,075,269 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001641172-25-014725 · ownership.xml · nonDerivative · entry 1 Era Regenerative Medicine Ltd · CIK 0002053961 · 10% owner D&D Source of Life Holding Ltd. · CIK 0001979652 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 28,214,789 F1 · kind: D&D Source of Life Holding Ltd. ("D&D"), participated in the Registrant's PIPE transaction. F2 · price: The purchase price per share was $0.93. F3 · balance_after: Includes 232,108 shares of common stock issuable upon exercise of currently exercisable warrants. F4 · ownership.nature: Era Regenerative Medicine Ltd.("ERM") holds all the shares in D&D. Dai Siqi, currently the sole director of ERM, has sole voting and dispositive power over the securities of the Registrant held directly by D&D. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.